MedPath

Amphetamine

Generic Name
Amphetamine
Brand Names
Adderall, Adzenys, Dyanavel, Evekeo, Mydayis
Drug Type
Small Molecule
Chemical Formula
C9H13N
CAS Number
300-62-9
Unique Ingredient Identifier
CK833KGX7E

Overview

Amphetamine, a compound discovered over 100 years ago, is one of the more restricted controlled drugs. It was previously used for a large variety of conditions and this changed until this point where its use is highly restricted. Amphetamine, with the chemical formula alpha-methylphenethylamine, was discovered in 1910 and first synthesized by 1927. After being proven to reduce drug-induced anesthesia and produce arousal and insomnia, amphetamine racemic mix was registered by Smith, Kline and French in 1935. Amphetamine structure presents one chiral center and it exists in the form of dextro- and levo-isomers. The first product of Smith, Kline and French was approved by the FDA on 1976. During World War II, amphetamine was used to promote wakefulness in the soldiers. This use derived into a large overproduction of amphetamine and all the surplus after the war finalized ended up in the black market, producing the initiation of the illicit abuse.

Background

Amphetamine, a compound discovered over 100 years ago, is one of the more restricted controlled drugs. It was previously used for a large variety of conditions and this changed until this point where its use is highly restricted. Amphetamine, with the chemical formula alpha-methylphenethylamine, was discovered in 1910 and first synthesized by 1927. After being proven to reduce drug-induced anesthesia and produce arousal and insomnia, amphetamine racemic mix was registered by Smith, Kline and French in 1935. Amphetamine structure presents one chiral center and it exists in the form of dextro- and levo-isomers. The first product of Smith, Kline and French was approved by the FDA on 1976. During World War II, amphetamine was used to promote wakefulness in the soldiers. This use derived into a large overproduction of amphetamine and all the surplus after the war finalized ended up in the black market, producing the initiation of the illicit abuse.

Indication

Amphetamine is indicated for the treatment of attention-deficit/hyperactivity disorders (ADHD) as well as for the treatment of central nervous system disorders such as narcolepsy. ADHD is a complex disorder associated with the substantial heterogeneity in etiology, clinical presentation, and treatment outcome. ADHD comes from a complex interplay between interdependent genetic and non-genetic factors which cause complex mental disorders in children and teenagers. On the other hand, narcolepsy is a chronic sleep disorder typically resenting during adolescence and characterized by excessive daytime sleepiness. Amphetamine is also being used nowadays off-label for the treatment of obesity, depression and chronic pain.

Associated Conditions

  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Chronic Pain
  • Depression
  • Narcolepsy
  • Obesity

FDA Approved Products

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2023/10/31
NDC:72162-1378
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Manufacturer:Sandoz Inc
Route:ORAL
Strength:6.25 mg in 1 1
Approved: 2022/02/28
NDC:0781-2368
MYDAYIS
Manufacturer:Takeda Pharmaceuticals America, Inc.
Route:ORAL
Strength:9.375 mg in 1 1
Approved: 2023/10/25
NDC:54092-474
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Manufacturer:Burel Pharmaceuticals, LLC
Route:ORAL
Strength:1.25 mg in 1 1
Approved: 2023/12/07
NDC:35573-464
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2019/07/22
NDC:63629-1973

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath